0001484612-21-000070.txt : 20211019 0001484612-21-000070.hdr.sgml : 20211019 20211019165810 ACCESSION NUMBER: 0001484612-21-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211015 FILED AS OF DATE: 20211019 DATE AS OF CHANGE: 20211019 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brottem John L. CENTRAL INDEX KEY: 0001823381 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39513 FILM NUMBER: 211331736 MAIL ADDRESS: STREET 1: 3052 ORCHARD DR. CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Outset Medical, Inc. CENTRAL INDEX KEY: 0001484612 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 200514392 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 BUSINESS PHONE: 669-231-8200 MAIL ADDRESS: STREET 1: 3052 ORCHARD DRIVE CITY: SAN JOSE STATE: CA ZIP: 95134 FORMER COMPANY: FORMER CONFORMED NAME: Home Dialysis Plus, Ltd. DATE OF NAME CHANGE: 20100219 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-10-15 0 0001484612 Outset Medical, Inc. OM 0001823381 Brottem John L. 3052 ORCHARD DRIVE SAN JOSE CA 95134 0 1 0 0 General Counsel Common Stock 2021-10-15 4 M 0 3500 9.48 A 18547 D Common Stock 2021-10-15 4 S 0 3500 49.0194 D 15047 D Common Stock 2021-10-19 4 M 0 1445 9.48 A 16492 D Common Stock 2021-10-19 4 S 0 1445 50.0 D 15047 D Non-Qualified Stock Option (right to buy) 9.48 2021-10-19 4 M 0 1445 0.0 D 2030-05-26 Common Stock 1445 60673 D Performance Options (right to buy) 9.48 2021-10-15 4 M 0 3500 0.0 D 2030-05-26 Common Stock 3500 17265 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on December 14, 2020. The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.60 to $49.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. This option vests if and to the extent that (i) the sum of (A) the 30-day closing price trading average of one Share of common stock of the Issuer ("Share") and (B) the Aggregate Cash Distributions is equal to or greater than $19.12 on any day following the expiration of the post-offering lockup period or (ii) the sum of (X) the value of all consideration that is distributable with respect to one Share in connection with a Corporate Event and (Y) the Aggregate Cash Distributions is equal to or greater than $20.86 as of the effective date of such Corporate Event. John L Brottem 2021-10-19